Today's Daily Dose brings you news about Atossa's near-term catalyst; Acer's progress in vascular Ehlers-Danlos syndrome trial; Eiger's phase II PREVENT study, and Mustang Bio's deal with St. Jude Children's Research Hospital for bubble boy gene therapy.
Original Article: MBIO & Bubble Boy Disease Gene Therapy, Busy Months Ahead For EIGR, UMRX